Description: This session discussion is about pricing on a unisex basis, regulatory developments, protecting against adverse selection, pricing considerations and experience analysis. From Record of the Society of Actuaries Vol. 15, No. 2.

Description: In this session, panel members speculate about changes to insurance company taxation, policyholder taxation and insurance product taxation in the 1980's. Both U.S. and Canadian viewpoints are shared.

Description: This presentation is an overview of the Meeting from the Record of the SOA Vol.6 No. 1. The session summarizes points from each concurrent session of the meeting and includes issues about the effect of governmental actions and consumerism on product design and pricing of the future, risk classification in the 1980's, nonforfeiture and valuation concerns in the 1980's and effect of taxation in the 1980's.

Description: This article is about the design and growth of the new variable life and annuity products.

Description: The article discusses the impact of changes made to Internal Revenue Code Section 7702 by the ConsolidatedAppropriations Act, 2021. The Consolidated Appropriations Act made changes to the interest rates used calculatethe Section 7702 premium and cash value funding limitations for life insurance contracts

Description: This 1979 session is about current developments in Life products. Products discussed: 1. Adjustable life 2. Universal life 3. Indexed coverages 4. Term Insurance plus accumulation fund 5. Level Premium Term to 100 6. Revertible Term

Description: This session from the 1983 SOA Hollywood, Florida Meeting discusses the Norris case, the Fair Insurance Practices Act and HR100, known as the Non-Discrimination in Insurance Act and the implications of these current developments regarding risk classification in the insurance industry and pension plans. From Record of the Society Vol. 9, No. 4

Description: This article reviews some of the highlights of th 2010 SOA Annual meeting including the impact on pricing resulting from Solvency II, Market Consistent Valuation of New Business - MCVNB, the latest on mortality, Standards of Practice in product development, managing risk in product design and a regulation update.